Skip to main content
KAPA logo

KAPA

Kairos Pharma, LTD.
$0.37 +0.00 (+0.54%) At close · Jul 2
Market Cap
$7.92M
Shares
21,411,198

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 11
Total Value: $335,986
Total Shares: 601,061

Institutional Ownership Trend

7 quarters

Holder Concentration

Across 11 13F filers · Δ vs Dec 31, 2025
Top Holder
38.6%
Sep 2024 → Mar 2026 · range 28.7% – 91.3%
+1.0 pts
Top 5
82.5%
Sep 2024 → Mar 2026 · range 74.6% – 100.0%
+4.3 pts
Top 10
100.0%
Sep 2024 → Mar 2026 · range 96.2% – 100.0%
+3.8 pts
HHI
2,133
Sep 2024 → Mar 2026 · range 1,511 – 8,357
Moderately concentrated+177

Quarterly Activity

vs Dec 31, 2025
New
4
Increased
2
Decreased
2
Sold Out
7
Unchanged
3
Holder count: -3
Institutional value: -44.7%
Shares held: -29.8%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 11 of 11
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1962011 CUSIP 48301N104 Visit website Investor relations